Loading clinical trials...
Loading clinical trials...
Retrospective Analysis of the Outcome of Patients Diagnosed With Hemophagocytic Lymphohistiocytosis (HLH) Treated at the S.C.Pediatric Oncohematology of the Regina Margherita Torino Hospital (OIRM)
Monocentric, observational, retrospective, no profit study aimed to analyze factors that are significantly impacting the outcome of patients diagnosed with HLH.
retrospective data collection to study: type of HLH familial vs secondary, sex, age, presence of infectious cause, involvement central nervous system ( SNC), hepatic involvement, presence of hemophagocytosis, presence of splenomegaly, presence of involvement of other organs, the value of neutrophils (PMN), the value of hemoglobin, platelets, albumin, triglycerides, ferritin, LDH, type of therapy and the response to therapy after 2 months
Age
0 - 18 years
Sex
ALL
Healthy Volunteers
No
AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita
Turin, Italy
Start Date
November 10, 2022
Primary Completion Date
February 24, 2023
Completion Date
April 30, 2023
Last Updated
May 25, 2023
39
ACTUAL participants
Observation
OTHER
Lead Sponsor
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
NCT04902807
NCT05882175
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions